نتائج البحث - "S. Bensfia"

1

13MO Safety and efficacy of tusamitamab ravtansine in combination with pembrolizumab ± chemotherapy in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05 phase II study)

المؤلفون: N. Isambert, T. Nagy, M. Ravoire, D. Rodriguez-Abreu, J.L. Gonzalez-Larriba, C.H. Huang, L. Paz-Ares, J. Roubec, F. Rey, G. Robinet, A. Onn, S. Shamai, S. Bensfia, C. Soufflet, A. Chevance, R. Veillon

المصدر: Journal of Thoracic Oncology. 18:S46-S47

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::015f49111341126023bf6a6a7ce39bec
https://doi.org/10.1016/s1556-0864(23)00267-8

View record in OpenAIRE

2

1261TiP CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)

المؤلفون: F.M. Esposito, J. Lee, S.Y. Rha, K.D. Penkov, A. Moisseev, M. Van Den Eynde, H. Prenen, M. Díez García, M. Gumus, T. Sagawa, M. Nechaeva, T. Kajiwara, H. Harputluoglu, L. Charbonnier, S. Bensfia, N. Yang, D-Y. Oh

المساهمون: UCL - SSH/IACS - Institute of Analysis of Change in Contemporary and Historical Societies

المصدر: Annals of Oncology, Vol. 33, no.7, p. 1124 (2022)

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::677730639d60a19a237e4d5cd58de896
https://hdl.handle.net/2078.1/273058

View record in OpenAIRE

3

75TiP Open-label, phase II study of tusamitamab ravtansine (SAR408701) in combination with pembrolizumab and with pembrolizumab + platinum-based chemotherapy +/− pemetrexed in patients with CEACAM5-positive nonsquamous NSCLC (CARMEN-LC05)

المؤلفون: L. Paz-Ares, S. Parakh, J. Park, C. Rojas, F. Orlandi, R. Veillon, N. Isambert, T. Nagy, V. Muller, B. Medgyasszay, D. Rodriguez-Abreu, A. Fernandez, A. Puaud, S. Bensfia, N. Yang, A. Spira

المصدر: Annals of Oncology. 33:S65-S66

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::900bb907bf2641dada54dbbe5f5c39c7
https://doi.org/10.1016/j.annonc.2022.02.084

View record in OpenAIRE

4

1364TiP Phase II single-arm trial of safety, antitumor activity, and pharmacokinetics of tusamitamab ravtansine (SAR408701) plus ramucirumab in CEACAM5-positive, metastatic, non-squamous, non-small cell lung cancer progressing on platinum-based chemotherapy and immunotherapy

المؤلفون: J. De Castro Carpeno, A. Blasco Cordellat, Byoung Cheol Cho, A-L. Bauchet, A. Tomova, S. Bensfia, Jaquelline Germano de Oliveira, C. Aguado de la Rosa, T.M. Kim, L. Vilà, G. Dy, Dolores Isla, C. Soufflet

المصدر: Annals of Oncology. 32:S1034-S1035

مصطلحات موضوعية: Antitumor activity, Chemotherapy, business.industry, medicine.medical_treatment, Hematology, Immunotherapy, medicine.disease, Ramucirumab, Oncology, Pharmacokinetics, Non squamous, Cancer research, medicine, Non small cell, Lung cancer, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::50d46e86bd869e5e4992c6cc7efd02ed
https://doi.org/10.1016/j.annonc.2021.08.1965

View record in OpenAIRE

5

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

المؤلفون: John Crown, Vincent Houe, Vladimir Semiglazov, S. Bensfia, John R. Mackey, A. Chan, Mary-Ann Lindsay, Louise Provencher, Miguel Martín, Michael F. Press, Wolfgang Eiermann, S. Sehdev, Guido Sauter, P. Drevot, Tadeusz Pienkowski, M. Buyse, S. Hitier, Mansoor N. Saleh, Saeed Sadeghi

المصدر: Annals of Oncology. 27:1041-1047

مصطلحات موضوعية: Adult, Oncology, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Cyclophosphamide, Receptor, ErbB-2, medicine.medical_treatment, Breast Neoplasms, Docetaxel, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Breast cancer chemotherapy, Breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, medicine, Humans, 030212 general & internal medicine, Aged, Chemotherapy, business.industry, Hematology, Middle Aged, medicine.disease, Chemotherapy regimen, Surgery, Regimen, Chemotherapy, Adjuvant, Doxorubicin, Lymphatic Metastasis, 030220 oncology & carcinogenesis, TAC Regimen, Female, Taxoids, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69340389194c0a09b5ae443b9a33337d
https://doi.org/10.1093/annonc/mdw098

View record in OpenAIRE

6

2549 Treatment patterns in patients (pts) with metastatic castrationresistant prostate cancer (mCRPC) previously treated with docetaxel (DOC)-based chemotherapy (CT): PROXIMA 1-year analysis

المؤلفون: L. Castillo, Gaetano Facchini, C. Pripatnanont, M. Butt, E.B. Ecstein-Fraisse, S. Hitier, S. Bensfia, Kwok Leung, S. Fava, Vasilios Karavasilis, Hideyuki Akaza, Duncan Wheatley, A. Silva, Giuseppe Procopio, M. Ö zgü roglu

المصدر: European Journal of Cancer. 51:S492-S493

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, medicine.disease, Prostate cancer, Docetaxel, Internal medicine, medicine, In patient, Previously treated, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d3397c19619fff45ae1ad8d719661d94
https://doi.org/10.1016/s0959-8049(16)31368-5

View record in OpenAIRE

7

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

المؤلفون: V. Valero, J.P. Crown, M-C Liu, Carla I. Falkson, S. Bensfia, S. Hitier, Arlene Chan, John R. Mackey, J Giermek, N. Xu, Michael F. Press, TA Shiftan, M. Martin, Wolfgang Eiermann, Tamás Pintér, P. Drevot, DJ Slamon, V. Bee-Munteanu, Nicholas J. Robert, M Jasiowka, Tommy Fornander

المصدر: Cancer Research. 76:S5-04

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7af83a45bef631e508f3a85937175c44
https://doi.org/10.1158/1538-7445.sabcs15-s5-04

View record in OpenAIRE

8

Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima

المؤلفون: G. Fountzilas, M. Butt, L. Castillo, A. Silva, Kwok Leung, Duncan Wheatley, C. Pripatnanont, E.B. Ecstein-Fraisse, Giuseppe Procopio, Hideyuki Akaza, Mustafa Ozguroglu, S. Bensfia, S. Fava, S. Hitier, Gaetano Facchini

المصدر: Annals of Oncology. 25:iv274

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Chemotherapy, Taxane, business.industry, medicine.medical_treatment, Hematology, Chemotherapy regimen, Prostate-specific antigen, Regimen, Docetaxel, Internal medicine, medicine, Hormonal therapy, business, Radiation oncologist, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5ce098126a59ac7527cf94bf638f9449
https://doi.org/10.1093/annonc/mdu336.40

View record in OpenAIRE

تنقيح النتائج